Pulmatrix, Inc.

As of June 30, 2026, Pulmatrix Inc carries a market capitalization of 5.24M, placing it among publicly traded companies globally. Its enterprise value stands at 4.19M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Pulmatrix Inc's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Pulmatrix Inc has 3.65M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Pulmatrix Inc maintains a current ratio of 4.70, meaning it holds 4.7x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Pulmatrix Inc posted a negative return on equity (ROE) of -111.99, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -85.40, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 2.00, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, Pulmatrix Inc's stock has declined approximately 69.07% over the past 52 weeks. The 50-day moving average sits at 1.31, while the 200-day moving average is 1.50.

Over the twelve months ended June 30, 2026, Pulmatrix Inc generated - - in revenue and converted that into -3.51M in net income, yielding earnings per share of -0.96. EBITDA reached -3.60M, while operating income came in at -3.60M.

These figures are as of June 30, 2026. Total book value stands at 1.39M, with working capital of 2.23M providing operational flexibility.

Pulmatrix Inc produced -3.42M in operating cash flow over the twelve months ended June 30, 2026. After subtracting - - in capital expenditures, free cash flow totaled -3.42M - equivalent to -0.94 per share.

These figures cover the twelve months ended June 30, 2026. The dividend payout ratio of 0.40 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -65.26: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow.

Pulmatrix Inc's most recent stock split took place on March 1, 2022 with a 20:1 split ratio.

As of June 30, 2026, Pulmatrix Inc has an Altman Z-Score of -129.36, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.